Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Breakpoint analysis by fluorescence in situ hybridization in myelodysplastic syndromes with t(3;12)(q26;p13) and expression of EVI1.
van de Loosdrecht AA, Kok K, de Vries B, van der Veen AY, van den Berg E, Esselink MT, Marynen P, Vellenga E, van Imhoff GW. van de Loosdrecht AA, et al. Among authors: van der veen ay, van den berg e, de vries b, van imhoff gw. Leukemia. 2000 Oct;14(10):1857-8. doi: 10.1038/sj.leu.2401895. Leukemia. 2000. PMID: 11021761 No abstract available.
Partial tetrasomy of 9P: a rare chromosomal abnormality in polycythaemia vera.
van de Loosdrecht AA, de Wolf JT, Noordhoek L, van den Berg E. van de Loosdrecht AA, et al. Among authors: van den berg e, de wolf jt. Br J Haematol. 2001 Mar;112(4):1086-7. doi: 10.1046/j.1365-2141.2001.02622-4.x. Br J Haematol. 2001. PMID: 11324639 Free article. No abstract available.
Lactic acidosis: pathophysiology, diagnosis and treatment.
Koornstra JJ, van de Loosdrecht AA, van Imhoff GW. Koornstra JJ, et al. Among authors: van de loosdrecht aa, van imhoff gw. Neth J Med. 2001 Dec;59(6):300-2. doi: 10.1016/s0300-2977(01)00174-7. Neth J Med. 2001. PMID: 11744183 No abstract available.
Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts.
van der Helm LH, Veeger NJ, Kooy Mv, Beeker A, de Weerdt O, de Groot M, Alhan C, Hoogendoorn M, Laterveer L, van de Loosdrecht AA, Koedam J, Vellenga E, Huls G. van der Helm LH, et al. Among authors: de weerdt o, de groot m, van de loosdrecht aa. Leuk Res. 2013 Aug;37(8):877-82. doi: 10.1016/j.leukres.2013.03.022. Epub 2013 Apr 28. Leuk Res. 2013. PMID: 23628552 Free article.
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.
Ossenkoppele GJ, Breems DA, Stuessi G, van Norden Y, Bargetzi M, Biemond BJ, A von dem Borne P, Chalandon Y, Cloos J, Deeren D, Fehr M, Gjertsen B, Graux C, Huls G, Janssen JJJW, Jaspers A, Jongen-Lavrencic M, de Jongh E, Klein SK, van der Klift M, van Marwijk Kooy M, Maertens J, Michaux L, van der Poel MWM, van Rhenen A, Tick L, Valk P, Vekemans MC, van der Velden WJFM, de Weerdt O, Pabst T, Manz M, Löwenberg B; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK). Ossenkoppele GJ, et al. Leukemia. 2020 Jul;34(7):1751-1759. doi: 10.1038/s41375-020-0725-0. Epub 2020 Feb 4. Leukemia. 2020. PMID: 32020044 Clinical Trial.
268 results